Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.19
0.10 (9.17%)
At close: Aug 18, 2025, 3:59 PM
1.19
0.42%
After-hours: Aug 18, 2025, 07:56 PM EDT
Fate Therapeutics Revenue
Fate Therapeutics reported an annual revenue of $13.63M, reflecting a -78.55% growth. For the quarter ending June 30, 2025, Fate Therapeutics generated $1.91M in revenue.
Revenue (ttm)
13.63M
Revenue Growth
-78.55%
Price / Sales Ratio
13.76
Revenue / Employee
75.31K
Employees
181
Market Cap
136.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 13.63M | -78.55% |
| Dec 31, 2023 | 63.53M | -34.03% |
| Dec 31, 2022 | 96.3M | +72.44% |
| Dec 31, 2021 | 55.85M | +77.66% |
| Dec 31, 2020 | 31.43M | +194.33% |
| Dec 31, 2019 | 10.68M | +125.32% |
| Dec 31, 2018 | 4.74M | +15.44% |
| Dec 31, 2017 | 4.11M | -6.72% |
| Dec 31, 2016 | 4.4M | +81.08% |
| Dec 31, 2015 | 2.43M | +Infinity% |
| Dec 31, 2014 | 0 | -100.00% |
| Dec 31, 2013 | 971K | -63.63% |
| Dec 31, 2012 | 2.67M | +128.21% |
| Dec 31, 2011 | 1.17M | n/a |